96 related articles for article (PubMed ID: 7752194)
41. Estimation of buspirone-bovine serum albumin binding by affinity capillary electrophoresis.
Markuszewski M; Frackowiak T; Kaliszan R
Acta Pol Pharm; 2001; 58(5):319-23. PubMed ID: 11876437
[TBL] [Abstract][Full Text] [Related]
42. Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Gaillard P; Carrupt PA; Testa B; Schambel P
J Med Chem; 1996 Jan; 39(1):126-34. PubMed ID: 8568799
[TBL] [Abstract][Full Text] [Related]
43. Isoindol-1-one analogues of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridyl)-p-iodobenzamido]ethyl]pipera zine (p-MPPI) as 5-HT1A receptor ligands.
Zhuang ZP; Kung MP; Mu M; Kung HF
J Med Chem; 1998 Jan; 41(2):157-66. PubMed ID: 9457239
[TBL] [Abstract][Full Text] [Related]
44. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
Koek W; Patoiseau JF; Assié MB; Cosi C; Kleven MS; Dupont-Passelaigue E; Carilla-Durand E; Palmier C; Valentin JP; John G; Pauwels PJ; Tarayre JP; Colpaert FC
J Pharmacol Exp Ther; 1998 Oct; 287(1):266-83. PubMed ID: 9765347
[TBL] [Abstract][Full Text] [Related]
45. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
46. N4-unsubstituted N1-arylpiperazines as high-affinity 5-HT1A receptor ligands.
Kuipers W; van Wijngaarden I; Kruse CG; ter Horst-van Amstel M; Tulp MT; IJzerman AP
J Med Chem; 1995 May; 38(11):1942-54. PubMed ID: 7783126
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and evaluation of heterocyclic carboxamides as potential antipsychotic agents.
Norman MH; Navas F; Thompson JB; Rigdon GC
J Med Chem; 1996 Nov; 39(24):4692-703. PubMed ID: 8941382
[TBL] [Abstract][Full Text] [Related]
48. Analogues of the 5-HT1A serotonin antagonist 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine with reduced alpha 1-adrenergic affinity.
Raghupathi RK; Rydelek-Fitzgerald L; Teitler M; Glennon RA
J Med Chem; 1991 Aug; 34(8):2633-8. PubMed ID: 1652026
[TBL] [Abstract][Full Text] [Related]
49. [The different mechanism of the inhibition by buspirone and its camphorimide analogs of 5-HT3-serotoninergic effects].
Kharin NA; Abramets II; Komissarov IV; Samoĭlovich IM
Biull Eksp Biol Med; 1993 Aug; 116(8):167-9. PubMed ID: 7903873
[TBL] [Abstract][Full Text] [Related]
50. Synthesis, anticonvulsant activity and 5-HT1A, 5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione.
Obniska J; Kołaczkowski M; Bojarski AJ; Duszyńska B
Eur J Med Chem; 2006 Jul; 41(7):874-81. PubMed ID: 16600439
[TBL] [Abstract][Full Text] [Related]
51. Quantitative and molecular analysis of buspirone hydrochloride polymorphs.
Sheikhzadeh M; Rohani S; Jutan A; Manifar T
J Pharm Sci; 2007 Mar; 96(3):569-83. PubMed ID: 17094124
[TBL] [Abstract][Full Text] [Related]
52. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
[TBL] [Abstract][Full Text] [Related]
53. Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR.
Intagliata S; Modica MN; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Romeo G
Bioorg Med Chem Lett; 2016 Aug; 26(16):4052-6. PubMed ID: 27396505
[TBL] [Abstract][Full Text] [Related]
54. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
55. Modification of sexual behavior of Long-Evans male rats by drugs acting on the 5-HT1A receptor.
Rehman J; Kaynan A; Christ G; Valcic M; Maayani S; Melman A
Brain Res; 1999 Mar; 821(2):414-25. PubMed ID: 10064829
[TBL] [Abstract][Full Text] [Related]
56. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and structure-activity relationships of a new model of arylpiperazines. 2. Three-dimensional quantitative structure-activity relationships of hydantoin-phenylpiperazine derivatives with affinity for 5-HT1A and alpha 1 receptors. A comparison of CoMFA models.
López-Rodríguez ML; Rosado ML; Benhamú B; Morcillo MJ; Fernández E; Schaper KJ
J Med Chem; 1997 May; 40(11):1648-56. PubMed ID: 9171874
[TBL] [Abstract][Full Text] [Related]
58. New benzocycloalkylpiperazines, potent and selective 5-HT1A receptor ligands.
el Ahmad Y; Laurent E; Maillet P; Talab A; Teste JF; Dokhan R; Tran G; Ollivier R
J Med Chem; 1997 Mar; 40(6):952-60. PubMed ID: 9083484
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
[TBL] [Abstract][Full Text] [Related]
60. Structure-activity relationship studies of CNS agents. Part VIII. Bulk tolerance around the protonation center of 4-substituted 1-(3-chlorophenyl)piperazines at 5-HT1A and 5-HT2 receptors.
Mokrosz JL; Charakchieva-Minol S; Paluchowska MH; Cegła MT
Pol J Pharmacol Pharm; 1992; 44(6):595-607. PubMed ID: 1305959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
